Teva Launches Generic Prometrium
Teva has launched a generic version of Prometrium capsules for the treatment of secondary amenorrhea, a cessation in menstrual periods for more than six months. The illness is due to a decrease in the...
View Article‘Teva’: Positive Results In Phase III Trial For Rhinitis Nasal Spray
Teva Pharmaceutical Industries reported positive results from Phase III clinical studies for its QNASL nasal spray. The spray is designed to treat seasonal allergic rhinitis (SAR) and perennial...
View Article‘Teva’ Launches Generic Drug Against Depression
Teva Pharmaceutical Industries launched its generic version of Forest Laboratories’ Lexapro, for the treatment of depression and generalized anxiety disorder. Teva will enjoy six months of marketing...
View ArticleClik here to view.
Teva CEO Erez Vigodman Resigns
February 7, 2017 | Teva Pharmaceutical Industries Ltd. announced last night that CEO Erez Vigodman has resigned. He will be replaced as interim president and CEO by Dr. Yitzhak Peterburg, who has...
View ArticleClik here to view.
Troubled Teva Appoints New CEO In Bid For Direction
This article was first published by The Times of Israel and was re-posted with permission. Teva Pharmaceutical Industries, Ltd. on September 11, 2017, appointed Kåre Schultz to become the company’s...
View ArticleTechnion Launches New Center For Entrepreneurship And Innovation
The Technion – Israel Institute of Technology announced this week that it was launching t-hub, a new Entrepreneurship and Innovation Center, after winning a NIS 10 million ($2.7 million) grant from the...
View ArticleFDA Grants Approval For Teva’s Generic Nasal Spray For Opioid Overdoses
The US Food and Drug Administration (FDA) granted its final approval recently of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a medication that can stop or reverse...
View ArticleTeva Teams Up With TAU, Weizmann Institute For Early-Stage Cancer Drug Research
Israel’s Teva Pharmaceutical Industries is partnering with Tel Aviv University (TAU) and the Weizmann Institute of Science, in separate agreements, for innovative drug research and development with a...
View ArticleClik here to view.
Israel’s Teva To Donate Millions Of Doses Of Potential Coronavirus Drug...
Israeli pharmaceutical giant Teva is set to donate millions of doses of a malaria drug to US hospitals in a bid to meet the demand to investigate the medicine as a potential treatment candidate for...
View Article
